Trodelvy
Early day motion 419, tabled 10 September 2021 by Mick Whitley (Labour). Signed by 45 members.
That this House welcomes the news that Trodelvy, a new treatment for women living with incurable metastatic triple negative breast cancer, has been licensed through Project Orbis for use in Great Britain; expresses concern that women now face a delay before they can access the drug and potentially miss out on extra months to live; further welcomes Breast Cancer Now’s Time for Trodelvy campaign, which is supported by over 200,000 people; and urges Gilead, the drug’s owner, to reach an agreement with NHS England to ensure all eligible women can access the drug immediately ahead of a NICE decision.
Signatures by party: Labour 22, Liberal Democrat 9, Conservative 4, DUP 3, Independent 2, Alba 1, Green 1, Labour/Co-operative 1, Scottish National Party 1, Social Democratic and Labour Party 1.